ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 80 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $88,851 | -76.2% | 59,234 | -74.8% | 0.03% | -75.0% |
Q2 2023 | $373,650 | -21.0% | 235,000 | -64.4% | 0.10% | -28.3% |
Q1 2023 | $473,179 | +23.8% | 659,575 | 0.0% | 0.14% | +26.1% |
Q4 2022 | $382,224 | +78.6% | 659,575 | +193.1% | 0.12% | +40.2% |
Q3 2022 | $214,000 | -60.1% | 225,000 | -49.7% | 0.08% | -64.8% |
Q2 2022 | $536,000 | – | 447,004 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 6,552,068 | $14,218,000 | 8.03% |
Versant Venture Management, LLC | 5,068,233 | $10,998,000 | 4.55% |
K2 PRINCIPAL FUND, L.P. | 1,653,874 | $3,589,000 | 0.29% |
RTW INVESTMENTS, LP | 7,483,757 | $16,240,000 | 0.24% |
Avoro Capital Advisors LLC | 6,950,000 | $15,082,000 | 0.24% |
Artal Group S.A. | 3,000,000 | $6,510,000 | 0.15% |
ALGERT GLOBAL LLC | 231,490 | $502,000 | 0.07% |
Virtus ETF Advisers LLC | 57,768 | $125,000 | 0.06% |
Pinz Capital Management, LP | 53,600 | $116,000 | 0.05% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 100,000 | $217,000 | 0.05% |